跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,839 条关于
“HLA*A2”
全部
2,839
临床试验
1,736
药物
511
机构
110
资讯
482
去年
T-Neuro Pharma Expands Alzheimer's Blood Biomarker Assay to Include All Patients
去年
MUSC Researchers Engineer CHAR-Tregs to Target Organ Rejection with Precision Immunosuppression
去年
Cancer Immunotherapy Strategies Repurposed for Autoimmune Disease Treatment Show Promise in Early Studies
去年
IDEAYA's Darovasertib and Crizotinib Combination Advances in Uveal Melanoma Trial
9个月前
IDEAYA Biosciences Completes Enrollment in Pivotal Trial for Darovasertib Combination in Metastatic Uveal Melanoma
去年
OSE Immunotherapeutics Reports Strong Financial Results and Pipeline Progress in 2024
2年前
OSE Immunotherapeutics Launches Phase 3 Trial of Tedopi® for Second-Line NSCLC
去年
OSE Immunotherapeutics Completes Enrollment in Phase 2 Trial Testing Tedopi Cancer Vaccine Combinations for NSCLC
2年前
Novel Treatment Landscape Expands for Uveal Melanoma with Multiple Promising Therapies in Development
去年
Servier and IDEAYA Biosciences Strike $530M Partnership for Uveal Melanoma Drug Darovasertib
第 1 页,共 49 页
上一页
下一页